Amprius Technologies (AMPX) Launches SiCore Cells, Is The Valuation Gap Justified?

Amprius Technologies SiCore launch puts aviation grade energy density in focus

Amprius Technologies (AMPX) has announced its second generation SiCore lithium ion cell that delivers 500 Wh/kg on conventional manufacturing equipment, aiming to support long endurance aviation and move ultra high energy batteries toward commercial scale.

Despite the new SiCore launch and a recent appearance at the Commercial UAV Expo, Amprius Technologies shares have been volatile. The 90 day share price return is down 51.09%, while the 1 year total shareholder return is 38.96%, suggesting sentiment has shifted from pressure to renewed interest around its long term story.

Scan beyond Amprius Technologies and compare it with hand picked electrification plays in our 39 power grid technology and infrastructure stocks to see how other companies are approaching long endurance and energy density challenges.

Amprius Technologies trades at a steep discount to analyst targets and to some estimates of intrinsic value, even after its recent pullback. Is that a genuine margin of safety, or a warning that the market’s caution is warranted?

Most Popular Narrative: 56.5% Undervalued

Amprius Technologies closed at $9.63 compared with a widely followed fair value narrative of $22.13 per share, which frames the current valuation gap in stark terms.

The industry's increasing need for lightweight, high-energy-density battery solutions (for drones, electric aviation, and next-gen vehicles) enables Amprius to maintain premium pricing and outperform on gross and net margins due to its demonstrated product performance advantages, evidenced by record energy density and recent customer wins (for example, AALTO/Airbus and U.S. Army).

Read the complete narrative.

Curious what kind of revenue ramp and margin shift would need to line up with that premium pricing story. The most followed narrative leans on aggressive growth, rising profitability and a rich future earnings multiple to justify that fair value. The detailed blueprint behind those assumptions is where the real debate starts.

Result: Fair Value of $22.13 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, that upside story for Amprius Technologies still hinges on scaling silicon anode production efficiently and avoiding revenue shocks from its concentration in aviation and drone customers.

Find out about the key risks to this Amprius Technologies narrative.

Another View on Amprius Technologies Valuation

While the fair value narrative for Amprius Technologies points to a large upside gap, the current P/S ratio of 12.9x tells a different story. It is far above the US Electrical industry average of 2.1x, above peer levels of 9.5x, and well above the 4.9x fair ratio that the market could move toward over time.

If sentiment cools or growth underdelivers, that gap gives the market room to compress the multiple. Are you comfortable with that valuation risk, or does the long term silicon anode story justify paying so far ahead of today’s sales?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

The split between upside potential and real concerns around Amprius Technologies is clear. Move quickly to review the evidence and form your own stance, including the 3 key rewards and 3 important warning signs.

Looking for more investment ideas beyond Amprius Technologies?

If Amprius Technologies has caught your attention, do not stop here. Broaden your watchlist now and give yourself more options when the market shifts.

• Target potential upside early by scanning 21 high quality undiscovered gems that combine solid fundamentals with room for wider market attention.
• Strengthen your downside protection by reviewing the 79 resilient stocks with low risk scores and focus on companies with more resilient risk scores.
• Build a sturdier core to your portfolio by checking the list of solid balance sheet and fundamentals (53 results) so your capital is working in businesses with healthier financial foundations.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com